Penetrating Injury: Clinical Trials

3 trials for Penetrating Injury, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 recruiting. 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1
Phase 41Not yet recruiting 1

Follow Penetrating Injury: new trials by email Literature Review of Penetrating Injury trials Research Report on Penetrating Injury

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Life-saving Treatment With Dry-plasma for Massive Bleeding in an Pre-hospital Setting
Dry plasma - Bleeding, Aortic Rupture
Phase 4Not yet recruitingVastra Gotaland Region6502026-01-012025-09-17
ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients
Epoetin Alfa 40000 UNT/ML, Sodium Chloride 0.9% - Trauma, Traumatic Injury
Phase 3RecruitingAustralian and New Zealand Intensive Care Research Centre25002020-11-092025-07-16
Social Determinants of Health in Patients With Penetrating Trauma Injuries Before and During the COVID-19 Pandemic
Postive SAR-CoV-2 PCR nasopharyngeal swab - Penetrating Injury, COVID-19
CompletedKern Medical Center8032019-03-012023-11-18

Narrower conditions

Wounds, Penetrating (3)  ·  Wounds, Nonpenetrating (2)  ·  Aortic Rupture (1)  ·  Brain Injuries, Traumatic (1)  ·  COVID-19 (1)  ·  Gastrointestinal Hemorrhage (1)  ·  Hemorrhage (1)  ·  Multiple Trauma (1)  ·  Wounds and Injuries (1)

Broader conditions

Wounds and Injuries (2)  ·  Aneurysm (1)  ·  Aneurysm, Ruptured (1)  ·  Aortic Aneurysm (1)  ·  Aortic Diseases (1)  ·  Brain Diseases (1)  ·  Brain Injuries (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Craniocerebral Trauma (1)  ·  Digestive System Diseases (1)  ·  Gastrointestinal Diseases (1)  ·  Infections (1)

Interventions

Epoetin Alfa (1)  ·  Sodium Chloride (1)

Sponsors

Australian and New Zealand Intensive Care Research Centre (1)  ·  Kern Medical Center (1)  ·  Vastra Gotaland Region (1)

Countries

Australia (1)  ·  Belgium (1)  ·  Finland (1)  ·  Germany (1)  ·  Ireland (1)  ·  New Zealand (1)  ·  Saudi Arabia (1)  ·  Slovenia (1)  ·  Switzerland (1)  ·  United States (1)

Top investigators

Associate Professor Craig French (1)  ·  Professor Alistair Nichol (1)

Results publications

PMID 26452709, PMID 40910602